As of 2024-12-12, the Relative Valuation of Johnson & Johnson (JNJ) is 194.25 USD. This relative valuation is based on P/E multiples. With the latest stock price at 146.24 USD, the upside of Johnson & Johnson based on Relative Valuation is 32.8%.
The range of the Relative Valuation is 168.97 - 230.82 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.2x - 33.3x | 31.6x |
| Forward P/E multiples | 28.7x - 39.3x | 33.3x |
| Fair Price | 168.97 - 230.82 | 194.25 |
| Upside | 15.5% - 57.8% | 32.8% |
| Date | P/E |
| 2024-12-11 | 24.04 |
| 2024-12-10 | 24.47 |
| 2024-12-09 | 24.53 |
| 2024-12-06 | 24.48 |
| 2024-12-05 | 24.52 |
| 2024-12-04 | 24.67 |
| 2024-12-03 | 24.98 |
| 2024-12-02 | 25.38 |
| 2024-11-29 | 25.42 |
| 2024-11-27 | 25.48 |
| 2024-11-26 | 25.34 |
| 2024-11-25 | 25.54 |
| 2024-11-22 | 25.44 |
| 2024-11-21 | 25.50 |
| 2024-11-20 | 25.10 |
| 2024-11-19 | 25.09 |
| 2024-11-18 | 25.38 |
| 2024-11-15 | 25.25 |
| 2024-11-14 | 24.90 |
| 2024-11-13 | 25.13 |
| 2024-11-12 | 25.03 |
| 2024-11-11 | 25.42 |
| 2024-11-08 | 25.49 |
| 2024-11-07 | 25.70 |
| 2024-11-06 | 25.89 |
| 2024-11-05 | 25.96 |
| 2024-11-04 | 25.95 |
| 2024-11-01 | 26.26 |
| 2024-10-31 | 26.21 |
| 2024-10-30 | 26.33 |
| 2024-10-29 | 26.25 |
| 2024-10-28 | 26.50 |
| 2024-10-25 | 26.38 |
| 2024-10-24 | 26.84 |
| 2024-10-23 | 27.19 |
| 2024-10-22 | 26.80 |
| 2024-10-21 | 26.70 |
| 2024-10-18 | 27.07 |
| 2024-10-17 | 26.97 |
| 2024-10-16 | 26.94 |
| 2024-10-15 | 26.91 |
| 2024-10-14 | 26.50 |
| 2024-10-11 | 26.47 |
| 2024-10-10 | 26.32 |
| 2024-10-09 | 26.34 |
| 2024-10-08 | 26.18 |
| 2024-10-07 | 26.16 |
| 2024-10-04 | 26.28 |
| 2024-10-03 | 26.32 |
| 2024-10-02 | 26.43 |